GB9319772D0 - Therapeutic agent - Google Patents
Therapeutic agentInfo
- Publication number
- GB9319772D0 GB9319772D0 GB939319772A GB9319772A GB9319772D0 GB 9319772 D0 GB9319772 D0 GB 9319772D0 GB 939319772 A GB939319772 A GB 939319772A GB 9319772 A GB9319772 A GB 9319772A GB 9319772 D0 GB9319772 D0 GB 9319772D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agent
- therapeutic
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0337—Animal models for infectious diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939319772A GB9319772D0 (en) | 1993-09-24 | 1993-09-24 | Therapeutic agent |
EP94927720A EP0725830A1 (en) | 1993-09-24 | 1994-09-26 | Expression of viral decoy proteins under the control of a locus control region and uses thereof |
JP7509661A JPH09505984A (en) | 1993-09-24 | 1994-09-26 | Expression of viral DECOY proteins under the control of locus control regions and their use |
CA002172073A CA2172073A1 (en) | 1993-09-24 | 1994-09-26 | Expression of viral decoy proteins under the control of a locus control region and uses thereof |
AU77026/94A AU697095B2 (en) | 1993-09-24 | 1994-09-26 | Expression of viral decoy proteins under the control of a locus control region and uses thereof |
PCT/GB1994/002092 WO1995008635A1 (en) | 1993-09-24 | 1994-09-26 | Expression of viral decoy proteins under the control of a locus control region and uses thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB939319772A GB9319772D0 (en) | 1993-09-24 | 1993-09-24 | Therapeutic agent |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9319772D0 true GB9319772D0 (en) | 1993-11-10 |
Family
ID=10742498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB939319772A Pending GB9319772D0 (en) | 1993-09-24 | 1993-09-24 | Therapeutic agent |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0725830A1 (en) |
JP (1) | JPH09505984A (en) |
AU (1) | AU697095B2 (en) |
CA (1) | CA2172073A1 (en) |
GB (1) | GB9319772D0 (en) |
WO (1) | WO1995008635A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2279675A1 (en) | 1995-12-15 | 1997-06-16 | Enzo Therapeutics, Inc. | Property effecting and/or property exhibiting constructs for localizing a nucleic acid construct within a cell for therapeutic and diagnostic uses |
US6689757B1 (en) | 1996-02-12 | 2004-02-10 | M.L. Laboratories Plc | Methods for vaccination and vaccines therefor |
ATE225668T1 (en) * | 1996-02-12 | 2002-10-15 | Cobra Therapeutics Ltd | NEW METHOD OF VACCINATION AND VACCINES THEREOF CONTAINING AN EPITOPE-CODING NUCLEIC ACID AND AN EPITOPE-CONTAINING PEPTIDE |
GB9609261D0 (en) * | 1996-05-02 | 1996-07-03 | Isis Innovation | Gene expression in monocytes and microphages |
CN104630149B (en) * | 2013-11-08 | 2018-08-21 | 中国科学院广州生物医药与健康研究院 | Xenogenic mitochondrial imported into the method in mammalian cell |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8718779D0 (en) * | 1987-08-07 | 1987-09-16 | Grosveld F G | Dna sequence & expression vector |
WO1991010453A1 (en) * | 1990-01-18 | 1991-07-25 | The United States Of America, As Represented By The Secretary, U.S. Department Of Commerce | Vector with multiple target response elements affecting gene expression |
GB9305759D0 (en) * | 1993-03-19 | 1993-05-05 | Medical Research Council And T | Hiv therapy method and agents |
GB9305761D0 (en) * | 1993-03-19 | 1993-05-05 | Medical Res Council | Disease model |
-
1993
- 1993-09-24 GB GB939319772A patent/GB9319772D0/en active Pending
-
1994
- 1994-09-26 AU AU77026/94A patent/AU697095B2/en not_active Ceased
- 1994-09-26 WO PCT/GB1994/002092 patent/WO1995008635A1/en not_active Application Discontinuation
- 1994-09-26 EP EP94927720A patent/EP0725830A1/en not_active Withdrawn
- 1994-09-26 JP JP7509661A patent/JPH09505984A/en active Pending
- 1994-09-26 CA CA002172073A patent/CA2172073A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1995008635A1 (en) | 1995-03-30 |
AU697095B2 (en) | 1998-09-24 |
CA2172073A1 (en) | 1995-03-30 |
AU7702694A (en) | 1995-04-10 |
EP0725830A1 (en) | 1996-08-14 |
JPH09505984A (en) | 1997-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9315808D0 (en) | Therapeutic agents | |
GB9312891D0 (en) | Therapeutic agents | |
GB9312893D0 (en) | Therapeutic agents | |
GB9309573D0 (en) | Therapeutic agents | |
GB9312806D0 (en) | Therapeutic agents | |
GB9305644D0 (en) | Therapeutic agents | |
GB9319772D0 (en) | Therapeutic agent | |
GB9316259D0 (en) | Therapeutic agents | |
GB9304110D0 (en) | Therapeutic agents | |
GB9307278D0 (en) | Therapeutic agents | |
GB9306031D0 (en) | Therapeutic agents | |
GB9305890D0 (en) | Therapeutic agents | |
GB9305645D0 (en) | Therapeutic agents | |
GB9305643D0 (en) | Therapeutic agents | |
GB9305642D0 (en) | Therapeutic agents | |
GB9305628D0 (en) | Therapeutic agents | |
GB9305619D0 (en) | Therapeutic agents | |
GB9305373D0 (en) | Therapeutic agents | |
GB9304525D0 (en) | Therapeutic agents | |
GB9304524D0 (en) | Therapeutic agents | |
GB9318930D0 (en) | Therapeutic agents | |
GB9316274D0 (en) | Therapeutic agents | |
GB9316261D0 (en) | Therapeutic agents | |
GB9316260D0 (en) | Therapeutic agents | |
GB9307318D0 (en) | Therapeutic agents |